![]() |
市场调查报告书
商品编码
1439714
介入放射设备 - 全球市场考量、竞争格局、市场预测 (2030)Interventional Radiology Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
预计 2024 年至 2030 年预测期内,全球介入放射设备市场规模将以 5.23% 的复合年增长率成长。 介入性放射设备需求的增加主要是由于慢性病和癌症盛行率的增加导致患者数量的增加,以及全球老年患者数量的增加。 介入性放射设备采用微创技术,这意味着不太严重的手术和更短的住院时间。 因此,由于全球降低医疗成本的需求不断增加,该设备的市场预计将扩大。 此外,人们对微创技术的认识和需求不断提高,照明渲染技术、即时成像等设备的技术进步将增强全球市场,推动 2024-2030 年预测期内介入放射设备市场的发展。
介入性放射设备市场动态
在介入性放射设备市场,由于各种原因,产品需求不断成长。
全球患者数量的不断增加正在增加市场对介入性放射设备的需求。 例如,由于遗传、老化、肥胖和不健康的生活方式等多种因素,全球市场正在经历心臟衰竭和中风等心血管疾病盛行率的增加,以及老年人口数量的增加。更容易患慢性病的患者预计会加强。 根据世界卫生组织 (WHO) (2022) 的数据,2019 年,心血管疾病 (CVD) 是世界上最主要的死亡原因之一。 2019年约有1,790万人死于CVD,占全球死亡人数的32%。 此外,据估计,1,790 万人死亡中约 85% 是由于心臟病和中风造成的。 此外,同一消息来源得出的结论是,超过四分之三的心血管疾病死亡发生在低收入和中等收入国家。 世界卫生组织的结论是,大多数心血管疾病可以透过解决行为风险因素来预防,例如吸烟、不健康饮食和肥胖、缺乏身体活动以及有害使用酒精。 此外,心臟衰竭的盛行率正在增加。 根据全球健康数据交换(2019),估计全球有 6,437 万人患有心臟衰竭。 在这种情况下,盛行率的不断增加将增加对用于诊断和治疗心血管疾病的许多介入放射设备(例如栓塞设备、MRI设备等)的需求。 因此,全球慢性病盛行率的不断上升将增加患者数量,从而增加对介入性放射设备的需求,从而增加2022-2028年研究期间的整体市场。
此外,根据世界卫生组织(2022)的数据,到 2030 年,世界上六分之一的人将年龄在 60 岁或以上。 全球60岁及以上人口比例将从2020年的10亿增加到14亿。 到2050年,全球60岁以上的人口数量将增加一倍。 2020 年至 2050 年间,80 岁及以上的人口预计将增加两倍,达到 4.26 亿。 因此,老年人口的成长将影响慢性病的盛行率,因为老化是慢性病的主要危险因子之一。 慢性病盛行率的不断上升将导致患者总数的增加,导致市场对介入性放射设备的需求增加。 因此,上述因素将在预测期内加强介入放射设备市场。
此外,大多数介入性放射设备都是微创的,这意味着这些设备不会在体内造成大切口,从而缩短患者的住院时间并加快康復速度。 因此,由于缩短住院时间和降低成本的需求迅速增加,对这些设备的需求将会增加。 因此,预计上述因素将推动2023-2028年介入放射设备市场的整体成长。
本报告研究和分析了全球介入放射设备市场,提供市场规模和预测、驱动因素和挑战、公司和产品概况等。
Interventional Radiology Devices Market By Product Type (MRI Systems, CT Scanners, Ultrasound Imaging Systems, Angiography Systems, Biopsy Devices, And Others), By Application (Cardiology, Oncology, Urology, Gastroenterology, Obstetrics, And Others), By End-User (Hospitals & Clinics, Ambulatory Surgical Centres, And Others), by geography is expected to grow at a steady CAGR forecast till 2030 owing to the increasing patient pool due to increasing prevalence of chronic disorders & cancer and due to increasing number of geriatric patients globally and the surging awareness and demand of minimally invasive treatment worldwide
Global interventional radiology devices market is expected to grow at a CAGR of 5.23% during the forecast period of 2024-2030. The increase in demand for interventional radiology devices is primarily attributed to the increasing patient pool due to an increasing prevalence of chronic disorders & cancer and due to the increasing number of geriatric patients globally. The interventional radiology devices works on minimally invasive techniques so it involves less severe surgical procedures, thereby leading to less hospitalization period. Thus, the rising demand of the reducing healthcare expenditure across the world is anticipated to bolster the market of the devices. Furthermore, the rising awareness and the demand of minimally invasive techniques and the technological advancements in the devices such as illumination rendering technology, real-time images, and others across the world are anticipated to bolster the market, thereby contributing to the growth of the interventional radiology devices market during the forecast period from 2024-2030.
Interventional Radiology Devices Market Dynamics:
The interventional radiology devices market is witnessing a growth in product demand owing to various reasons.
The increasing patient pool worldwide is increasing the demand of the interventional radiology devices in the market. For instance, the increasing prevalence of cardiovascular disorders such as, heart failure and stroke worldwide due to various factors such as, genetic, age, obesity, and unhealthy lifestyles and increasing number of geriatric patients prone to chronic disorders across the world are anticipated to bolster the market. According to World Health Organization (WHO) 2022, in 2019, cardiovascular diseases (CVDs) was one of the leading cause of death globally. It was estimated that around 17.9 million people died from CVDs in 2019, representing 32% of all the global deaths. It was also estimated that out of 17.9 million deaths, approximately 85% of them were due to heart attack and stroke. Additionally, as per the same source, it was concluded that over three quarters of CVD deaths take place in low- and middle-income countries. WHO concluded that most of the cardiovascular diseases can be prevented by addressing behavioral risk factors such as tobacco use, unhealthy diet and obesity, physical inactivity and harmful use of alcohol. Additionally, the prevalence of heart failure is also rising. According to Global Health Data Exchange 2019, it was estimated that globally, 64.37 million people were suffering from heart failure. In this case, the increasing prevalence will increase the demand of many interventional radiology devices such as embolization devices, MRI devices for the diagnosis and treatment of the cardiovascular disorders. Thus, the increasing prevalence of chronic disorders globally will increase the patient number, thereby increasing the demand of the interventional radiology devices, therefore anticipated to bolster the overall market growth in the study period of 2022 - 2028.
Moreover, according to WHO 2022, by 2030, one in six people in the world will be aged 60 years or more. The share of the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion globally. By 2050, the world's population of people aged 60 years and older will double (2.1 billion). The number of person that are aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million. Thus, the number of geriatric population is increasing which will in turn affect the prevalence of chronic ailments as age is one of the major risk factor for these disorders. The increased prevalence of chronic disorder will ultimately increase the overall patient pool, thereby leading to the increased demand of the interventional radiology devices in the market. Hence, the above factor will bolster the market of interventional radiology devices in the forecast period.
Moreover, majority of the interventional radiology devices are minimally invasive devices as these devices do not provide any major incisions on the body which ultimately reduces the hospitalization stay, thereby resulting in the early recovery of the patient. Therefore, the surging need of the less hospitalization stay and cost will increase the demand of such devices. Therefore, the above factor is anticipated to propel the overall market growth of the interventional radiology devices in the year 2023 - 2028.
Thus, due to the increasing patient number globally, increasing prevalence of chronic disorders and rising need of less hospitalization cost, will pave the way to a rising demand for interventional radiology devices, in turn increasing the interventional radiology devices market growth.
However, higher costs of radiology devices and lack of skilled professionals in remote areas may hinder the overall market growth of the interventional radiology devices.
The ongoing COVID-19 pandemic has slightly impacted the market for interventional radiology devices. At the onset of the disease, there was a significant shortage, attributed to the imposition of stringent lockdowns to curb the spread of the virus. Hospital admissions for patients suffering from cancers and other chronic disorders were not a priority in comparison to the patients that were suffering from coronavirus. The production of certain medical devices was shut down. Furthermore, surgeries were temporarily stopped during the pandemic. To reduce the COVID-19 transmission risk, many surgical centers have postponed and canceled the semi-urgent and elective cases. However, with masses being vaccinated, the interventional radiology devices market has picked momentum.
Interventional Radiology Devices Market Segment Analysis:
Interventional Radiology Devices Market by Product Type (MRI Systems, CT Scanners, Ultrasound Imaging Systems, Angiography Systems, Biopsy Devices, and Others), by Application (Cardiology, Oncology, Urology, Gastroenterology, Obstetrics, and Others), by End-User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the application segment of the interventional radiology devices market, the oncology interventional radiology devices are estimated to hold a significant share in the interventional radiology devices market during the forecast period (2024-2030). This can be ascribed to the increasing prevalence of cancer globally and due to wide application circle associated with the segment.
According to the study conducted by the World Health Organization (WHO), it was estimated that cancer is one of the leading cause of the death globally. As per what the WHO had stated, cancer has nearly caused 10 million deaths in the year 2020. The most common cancers are breast, lung, colon and rectum and prostate cancers with breast cancer reported 2.26 million cases globally in the year 2020. Also in the year 2020, globally, there were 2.21 million cases of lung cancer, 1.93 million cases of colon and rectum cancer, and 1.41 million cases of prostate cancer. As per the same source it was estimated that each year, approximately 400,000 children develop cancer. The increasing prevalence of cancers globally will increase the demand of interventional radiology devices used in cancer. Therefore, increasing the overall market growth of the interventional radiology devices in the forecast period.
Moreover, tobacco use, alcohol consumption, unhealthy diet, physical inactivity and air pollution are risk factors for cancer and other non-communicable diseases. The increasing use of tobacco among the people will increase the prevalence of cancer, thereby increasing the demand of the oncology segment in the interventional radiology devices. For instance, according to American Lung Association, State of Tobacco Control 2022, a 2022 study found that menthol cigarettes were responsible for 1.5 million new smokers among African Americans in 2022. The study concluded that from 2019 to 2022, disposable e-cigarette use skyrocketed by more than 23 times among high school e-cigarette users (from 2.4% to 55.8%) and more than 14 times among middle school e-cigarette users (from 3% to 43.8%). Additionally, according to National Youth Tobacco Survey 2020, it was estimated that in 2019-2020 more than 23.6% of high school students in the U.S. use at least one tobacco product, including e-cigarettes. As per the same source, smoking is the number one preventable cause of death in the U.S. killing over 480,000 people per year. The increasing use of tobacco will increase the prevalence of cancer, thereby increasing the demand of oncology segment in the year 2023 - 2028.
Thus, owing to the increasing prevalence of cancer, surging use of tobacco is a risk factor, there will be an increase in the demand for oncology segment in interventional radiology devices, which in turn will drive the interventional radiology devices market growth.
North America is expected to dominate the overall Interventional Radiology Devices Market:
Among all the regions, North America is expected to account for the significant share in the global interventional radiology devices market.
Increasing patient pool in the region and the rising need in the improvement in the quality of the patient care will increase the product demand in the North America. Further, the increasing prevalence of chronic disorders such as diabetes, cardiovascular disorders, hypertension, infections, and many more due to high consumption of processed food & lifestyle changes, and growing incidence of obesity is anticipated to overall propel the market growth of the system in the region. Additionally, increasing number of geriatric population susceptible to chronic medical ailments such as diabetes, neurological disorders, and cardiovascular diseases, and other will increase the demand for interventional radiology devices in North America, leading to a rise in the overall interventional radiology devices market growth.
For instance, as per the data published by the International Diabetes Federation (IDF), Diabetes Atlas Tenth edition 2022, in the year 2023, approximately 51 million adults (20-79 years) were living with diabetes in North America and the total number of people living with diabetes is projected to rise to 7 million by 2030 and 63 million by 2045. As per the same source, it is estimated that almost 1 in 4 (240 million) adults living in North America with diabetes are undiagnosed. Moreover, as per the IDF, Diabetes Atlas Tenth edition 2022, in the year 2023, more than 1.2 million children and adolescents (0-19 years) were living with type 1 diabetes and one in six live births (21 million) were affected by diabetes during pregnancy. As per above statistics, it can be concluded that the prevalence of diabetes mellitus in North America is increasing, this may increase the overall patient number suffering from any disease in the region, ultimately increasing the demand of interventional radiology devices used in the treatment and diagnosis of the chronic disorders. Thus, increasing the overall market growth of interventional radiology devices in the forecast period.
Furthermore, unhealthy life is contributing for an increase in the prevalence of chronic disease like cardiovascular disease and hypertension. Adults who eat a healthy diet live longer, have a lower risk of obesity, heart disease, type 2 diabetes, and certain cancers. Most Americans, however, do not follow a healthy lifestyle. As per the Centers for Disease Control and Prevention (CDC), 2022, fewer than 1 in 10 adults and adolescents eat enough fruits and vegetables, and 9 in 10 Americans aged 20 years or older consume more than the recommended amount of sodium. The unhealthy lifestyle will increase the prevalence of chronic disorders in the forecast period owing to increase the demand of interventional radiology devices in the North America market.
For instance, according to Government of Canada 2022, by the year 2030 seniors are expected to over 9.5 million and make up 23% of Canadians. Moreover, as per the same source, by 2036, the average life expectancy at birth for women will rise to 86.2 years from the current 84.2 and to 82.9 years from the current 80 for men. Geriatric patients are more susceptible to cancer and chronic ailments owing to the increased hospital admissions. This will increase the demand of the interventional radiology devices used in the treatment and diagnosis of chronic disorders in the geriatric patients, thereby leading to the increase demand of the interventional radiology devices in the North America in the forecast period of 2022 - 2028.
Thus, all the above-mentioned factors are anticipated to propel the market for interventional radiology devices in the North America.
Interventional Radiology Devices Market Key Players:
Some of the key market players operating in the Interventional Radiology Devices market include General Electric, Koninklijke Philips N.V., Carestream Health, ESAOTE SPA, Hitachi, Ltd., Hologic, Inc., Shimadzu Corporation, Siemens Healthcare GmbH, CANON MEDICAL SYSTEMS CORPORATION, Samsung Medison Co., Ltd., Medtronic Plc, Agfa-Gevaert Group, Teleflex Incorporated, Cook, Analogic Corporation, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Trivitron Healthcare, Stryker Corporation, Olympus Corporation, Toshiba Medical Systems, among others.
Recent Developmental Activities in the Interventional Radiology Devices Market:
In May 2022, XACT Robotics, developer of the world's first and only comprehensive robotic system for interventional radiology, announced that the XACT ACE Robotic System received US Food and Drug Administration (FDA) clearance for a modification to its cleared XACT ACE Robotic System designed to support robotic insertion and steering of ablation probes during ablation clinical procedures.
In March 2022, Guerbet, a global leader in medical imaging, announced the launch of microcatheters and a new line of guidewires, resulting in a broad range of interventional imaging and embolization solutions.
In April 2022, Siemens Healthineers AG, a leading medical technology, announced that it has successfully completed the acquisition of Varian Medical Systems, Inc., an American radiation oncology treatments and software maker. The combined company is creating a unique, highly integrated portfolio of imaging, laboratory diagnostics, artificial intelligence and treatment for the global to fight against cancer.
In December 2020, Samsung Electronics Co. Ltd, a global leading medical device company, announced the launch of their premium diagnostic imaging solutions in ultrasound, digital radiography, and mobile computed tomography at the Radiological Society of North America (RSNA) 2020. This strategic initiative assisted the company in expanding their product portfolio in interventional radiology industry.
Key Takeaways from the Interventional Radiology Devices Market Report Study
Target Audience who can be benefited from this Interventional Radiology Devices Market Report Study
Frequently Asked Questions for Interventional Radiology Devices Market:
An Interventional Radiology (IR) Device, refers to a range of medical devices and techniques which rely on the use radiological image guidance such as X-ray fluoroscopy, ultrasound, computed tomography [CT] or magnetic resonance imaging [MRI], and others to precisely target therapy. Most IR treatments are minimally invasive alternatives to open and laparoscopic surgery.
Global interventional radiology devices market is expected to grow at a CAGR of 5.23% during the forecast period of 2024-2030.
The interventional radiology devices market is witnessing a positive market growth owing to the increasing patient pool due to the increasing prevalence of chronic disorders & cancer and due to increasing number of geriatric patients globally. Additionally, the rising demand for reducing healthcare expenditure due to lesser hospital stay with the use of interventional radiology devices will propel the overall market growth of the device in the upcoming years. Furthermore, the surging awareness and demand of minimally invasive treatment and the technological advancements in the devices such as illumination rendering technology, real-time images, and others across the world are anticipated to bolster the market.
Some of the key market players operating in the interventional radiology devices market include General Electric, Koninklijke Philips N.V., Carestream Health, ESAOTE SPA, Hitachi, Ltd., Hologic, Inc., Shimadzu Corporation, Siemens Healthcare GmbH, CANON MEDICAL SYSTEMS CORPORATION, Samsung Medison Co., Ltd., Medtronic Plc, Agfa-Gevaert Group, Teleflex Incorporated, Cook, Analogic Corporation, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Trivitron Healthcare, Stryker Corporation, Olympus Corporation, Toshiba Medical Systems, and others.
North America is expected to hold the highest share in the revenue in the interventional radiology devices market during the forecast period. Increasing patient pool due to increasing prevalence of chronic disorders & cancer and due to increasing number of geriatric patients globally and increasing demand and awareness of the minimally invasive techniques will propel the interventional radiology devices in the North America, leading to a rise in the overall interventional radiology devices market growth in this region.